The Unseen Cost: Why Medical Device Companies Can’t Ignore Regulatory Budgeting | |
In my discussions with various companies, a recurring theme is the reactive nature of budgeting for regulatory expenses. The process typically begins with an internal acknowledgment that “something” needs to be done – whether it’s hiring a regulatory consultant or conducting product testing. This realisation triggers a search for service providers, usually involving requests for multiple quotes to ensure competitive pricing. However, this approach often leads to delays, as the responsibility for approving these expenditures usually falls on the shoulders of finance directors or controllers who may not have a deep understanding of the regulatory landscape. | |
| Related Link: Click here to visit item owner's website (0 hit) | |
| Target State: All States Target City : New York City Last Update : Sep 10, 2024 3:34 AM Number of Views: 39 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |